Christopher Paul German, Corporate Controller & CAO at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 344 shares at $54.23 ($19K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Scheduled sale ($19k) by Corporate Controller & CAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RYTM | SELL | 2025-08-14 | $143K | — | Filing → |
| RYTM | SELL | 2025-07-11 | $459K | — | Filing → |
| RYTM | SELL | 2025-06-12 | $278K | — | Filing → |